Form 4 for SRTA Strata Critical Medical, Inc.
Accepted 2024-03-15 00:00:00 ET · period of report 2024-03-13 · accession 0001779128-24-000032 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-03-15 | 2024-03-13+ | SRTA | Bacon Seth J | CEO, Trinity Air Medical | S - Sale | $2.69 | -2,451 | 342.4K | -0.7% | -$6,595 |
| 2024-03-15 | 2024-03-14 | SRTA | Bacon Seth J | CEO, Trinity Air Medical | F - Tax | $3.94 | -180 | 342.2K | -0.1% | -$709.20 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A common stock, $0.0001 par value per share | 2024-03-13 | S | D | 1,239 | $2.76 | 343,593 | D | — | — | (F1) Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.655 to $2.875, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. |
| 2 | Common | Class A common stock, $0.0001 par value per share | 2024-03-14 | F | D | 180 | $3.94 | 342,201 | D | — | — | |
| 3 | Common | Class A common stock, $0.0001 par value per share | 2024-03-14 | S | D | 1,212 | $2.62 | 342,381 | D | — | — | (F1) Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.55 to $2.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. |